Lung MRI for experimental drug research

Area of Science:

• Pulmonary Medicine
• Medical Imaging
• Preclinical Research

Background:

• Current methods for assessing airways disease treatments in preclinical models are invasive and terminal.
• Magnetic Resonance Imaging (MRI) offers a flexible, non-invasive approach for lung imaging.

Purpose of the Study:

• To explore MRI techniques for routine drug testing in rodent models of airways diseases.
• To highlight MRI applications in experimental lung research, focusing on disease aspects and pharmacological studies.

Main Methods:

• Review of proton MRI techniques and hyperpolarized gas MRI.
• Application of MRI for analyzing lung inflammation, ventilation, emphysema, fibrosis, and sensory nerve activation.
• Discussion of MRI's role in pharmacological studies for lung disease models.

Main Results:

• MRI enables longitudinal tracking of disease progression in the same animal, reducing animal numbers.
• MRI can detect disease changes earlier than invasive inflammatory markers.
• The technique offers insights into various lung disease aspects and treatment efficacy.

Conclusions:

• MRI provides a valuable non-invasive tool for preclinical lung disease research and drug development.
• It enhances animal welfare, reduces experimental costs, and potentially shortens study durations.
• Understanding MRI's advantages and limitations is crucial for its effective application in experimental lung research.